ResMed Inc. Revenue 2009–2025
ResMed Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ResMed Inc. revenue for the quarter ending March 31, 2026 was 1.4 B, a 10.81% increase year-over-year.
- ResMed Inc. revenue for the twelve months ending March 31, 2026 was 5.5 B, a 12.64% increase year-over-year.
- ResMed Inc. annual revenue for 2025 was 5.1 B, a 9.84% increase from 2024.
- ResMed Inc. annual revenue for 2024 was 4.7 B, a 10.95% increase from 2023.
- ResMed Inc. annual revenue for 2023 was 4.2 B, a 18.02% increase from 2022.
- ResMed Inc. annual revenue for 2022 was 3.6 B.
ResMed Inc. (RMD) — Frequently Asked Questions
ResMed Inc. (RMD) is a publicly traded US company. It has a market capitalization of $28.35B. In fiscal 2025 it reported revenue of $5.15B and net income of $1.40B. Explore RMD's stock price, financial statements, earnings history, margins and key ratios below.
What is ResMed Inc.'s market cap?
ResMed Inc. (RMD) has a market capitalization of $28.35B.
What is the RMD stock price?
RMD trades at $192.39 (-0.61% on the day).
How much revenue does ResMed Inc. make?
ResMed Inc. reported revenue of $5.15B in fiscal 2025.
Is RMD profitable?
In fiscal 2025, ResMed Inc. reported net income of $1.40B.